The start-up, which operates within the Meytag incubator, has launched its first pilot in Philadelphia.
New biomed start-up RX DrugOn has raised NIS 2.8 million from Capital Point Ltd. (TASE:CPTP) and private investors. Capital Point's investment was made through its fully-owned subsidiary Meytag Technological Incubator in Katzrin on the Golan Heights.
RX DrugOn develops software and hardware systems integrating targeted publications for customers of pharmacies presenting information about medication dosages. The start-up, which operates within the Meytag incubator, has launched its first pilot in Philadelphia, Pennsylvania.
RX DrugOn was founded by CEO Yaron Front and CTO Ofer Haramati. Front founded Anota, which was sold to Jacada in 2002 for $640,000, and Spectrom Dynamics.
Published by Globes [online], Israel business news - www.globes-online.com - on May 3, 2009
© Copyright of Globes Publisher Itonut (1983) Ltd. 2009